Table 2. New definitions of DRD, DRD-plus, and DRD look-alike.
| Previous name | Previous definition4,21 | New definition |
|---|---|---|
| DRD | A syndrome of selective nigrostriatal dopamine deficiency caused by genetic defects in the dopamine synthetica pathway without nigral cell lossa | A group of non-neurodegenerative disorders by genetic defects involving nigrostriatal dopaminergic system with cardinal manifestationsb (namely, DRD phenotype) |
| DRD-plus | A group of disorders caused by genetic defects in the dopamine synthetica pathway without nigral cell lossa that have features of DRD ‘plus’ those features that are not seen in DRD | A group of non-neurodegenerative disorders by genetic defects involving nigrostriatal dopaminergic system with dopa-responsiveness plus additional featuresc (namely, DRD-plus phenotype) that are not seen in DRD |
| DRD look-alike | - | A group of 1) neurodegenerative or non-neurodegenerative disorders without involving the nigrostriatal dopaminergic system or 2) neurodegenerative disorders with involving nigrostriatal dopaminergic system, that could present with dystonia responsive to dopaminergic drugs |
DRD = dopa-responsive dystonia.
aWhich are deleted in the new proposal to include additional disorders; bThose include dystonia and/or parkinsonism, and dramatic response to levodopa without long-term motor complications; cThose include infantile onset, developmental delay, psychomotor retardation, seizure, hypotonia, drowsiness, recurrent hyperthermia, ptosis, cerebellar dysfunction, poor responsiveness to levodopa or other dopaminergic drugs.